Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Spinal Mobilization With Arm Movement and Kaltenborn Mobilization in Adhesive Capsulitis (SMWAM)

23. juli 2026 oppdatert av: Riphah International University

Effects of Spinal Mobilization With Arm Movement and Kaltenborn Mobilization on Pain, Range of Motion, Functional Reaching, and Disability in Adhesive Capsulitis

To compare the effects of spinal mobilization with arm movement and Kaltenborn Mobilization on pain, range of motion, functional reaching, and disability in patients with Adhesive Capsulitis.

Studieoversikt

Detaljert beskrivelse

A randomized clinical trial compared the effectiveness of Kaltenborn mobilization and muscle energy techniques in individuals with adhesive capsulitis. Seventy-six participants were randomly allocated into two treatment groups. Pain, shoulder range of motion, and disability were assessed using the Numeric Pain Rating Scale (NPRS), goniometry, and the Shoulder Pain and Disability Index (SPADI) at baseline and after four weeks of treatment. The findings demonstrated that Kaltenborn mobilization produced greater improvements in pain reduction, shoulder range of motion, and functional ability.

A quasi-experimental study evaluated the effects of Kaltenborn mobilization and muscle energy techniques in patients with chronic adhesive capsulitis. Participants received their respective manual therapy interventions in combination with conventional rehabilitation. Shoulder external rotation, shoulder abduction, pain intensity, and functional disability were assessed before and after treatment. The results indicated that Kaltenborn mobilization was more effective than muscle energy techniques in improving shoulder mobility, reducing pain, and enhancing functional outcomes.

A randomized controlled trial compared muscle energy techniques with Kaltenborn mobilization for improving shoulder range of motion in individuals with adhesive capsulitis. Outcomes were assessed at baseline and during follow-up using goniometric measurements. The findings showed that muscle energy techniques produced greater improvements in shoulder flexion and abduction, whereas rotational movements demonstrated no clear advantage over Kaltenborn mobilization.

A randomized clinical trial investigated the effects of Spinal Mobilization with Arm Movement (SMWAM) compared with the Maitland mobilization technique on shoulder function. Pain, shoulder range of motion, and muscle activity were evaluated before and after treatment. The results demonstrated that spinal mobilization with arm movement effectively reduced pain, normalized shoulder muscle activity, and increased shoulder range of motion.

A randomized controlled trial compared the effects of anterior and posterior Grade III Kaltenborn glides on shoulder function in patients with adhesive capsulitis. External rotation and functional ability were evaluated using goniometric measurements and the Shoulder Pain and Disability Index (SPADI). The findings indicated that posterior gliding mobilization resulted in greater improvements in external rotation and shoulder function than anterior gliding.

A randomized controlled trial examined the immediate effects of Spinal Mobilization with Arm Movement (SMWAM) on shoulder performance. The intervention involved cervical spinal mobilization combined with repeated active arm abduction. The study reported immediate improvements in shoulder movement and suggested that SMWAM enhances shoulder function by correcting cervical spinal alignment and stimulating joint mechanoreceptors.

Although both Spinal Mobilization with Arm Movement (SMWAM) and Kaltenborn Mobilization have demonstrated beneficial effects in reducing pain and improving shoulder mobility, existing evidence has primarily evaluated these techniques independently or compared them with other manual therapy approaches. Direct comparative evidence between SMWAM and Kaltenborn Mobilization in individuals with adhesive capsulitis remains limited, particularly regarding their effects on pain, range of motion, functional reaching, and disability. Therefore, further comparative research is warranted to determine the more effective intervention for optimizing functional recovery in patients with adhesive capsulitis.

Studietype

Intervensjonell

Registrering (Antatt)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Rekruttering
        • Jinnah Hospital
        • Ta kontakt med:
      • Lahore, Punjab Province, Pakistan, 54000
        • Rekruttering
        • Alfalah Medical Center
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Age 35-50 years
  • Both male and female genders
  • Pain rating 3 to 7 on NPRS for at least 3 months
  • Idiopathic frozen shoulder
  • Stage II and III frozen shoulder
  • Positive Apley's Scratch test
  • Unilateral frozen shoulder
  • Frozen shoulder with at least 25% restricted ROM
  • Presence of global restriction in passive range of motion (PROM) in a capsular pattern (ER > ABD > IR)

Exclusion Criteria:

  • Arthritic shoulder
  • Rotator cuff disease
  • Post-traumatic stiff shoulder
  • Post-CABG shoulder-hand syndrome
  • Post-stroke frozen shoulder
  • Bilateral frozen shoulder
  • Complex Regional Pain Syndrome
  • Any fracture or other injury
  • Any systemic illness
  • Any inflammatory disease (Rheumatoid arthritis, gout)
  • Any neurological disease
  • Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty
  • Tendon calcification

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Spinal Mobilization with Arm Movement
Participants will be seated upright while the therapist applies a sustained transverse glide to the C4 spinous process toward the side opposite the affected shoulder. The glide will be maintained as the participant actively abducts the affected arm to the pain-free or maximum tolerated range and returns to the starting position. The technique will be performed for 10 repetitions per session, ensuring controlled movement, proper posture, and patient comfort throughout the intervention.
Intervention: Spinal Mobilization with Arm Movement (SMWAM) Position: Participant seated upright with neutral spine and head posture Technique: Sustained transverse glide applied to the C4 spinous process toward the side opposite the affected shoulder during active shoulder abduction Movement: Active shoulder abduction to the pain-free or maximum tolerated range, followed by return to the starting position while maintaining the glide Dosage: 10 repetitions per session Purpose: To reduce pain, improve shoulder mobility, and enhance functional movement.
Andre navn:
  • SMWAM
Eksperimentell: Kaltenborn Mobilization
Following the application of a moist hot pack, participants will receive Kaltenborn Grade I glenohumeral traction followed by Grade III ventral glide and Grade III caudal glide in the same treatment session. Each mobilization will be performed for 15 repetitions, with a 30-second sustained hold and 10-second rest between repetitions, for a total treatment time of approximately 10 minutes. The techniques will be applied in standardized patient positions with appropriate scapular stabilization to improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Intervention: Kaltenborn Mobilization Technique (KMT) Pre-treatment: Moist hot pack application Techniques: Grade I glenohumeral traction, Grade III ventral glide, and Grade III caudal glide Dosage: 15 repetitions of each technique with a 30-second hold and 10-second rest between repetitions Duration: Approximately 10 minutes per session Purpose: To improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Andre navn:
  • KMT

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain by Numeric Pain Rating Scale (NPRS)
Tidsramme: 6 weeks
The Numeric Pain Rating Scale (NPRS) is an 11-point self-reported scale (0 = no pain, 10 = worst imaginable pain) used to assess pain intensity in clinical and research settings.
6 weeks
Range of Motion (External Rotation, Abduction, Internal Rotation)
Tidsramme: 6 weeks
A goniometer is a standard clinical instrument used to measure joint range of motion (ROM)
6 weeks
Functional Disability
Tidsramme: 6 weeks
The Shoulder Pain and Disability Index (SPADI) is a 13-item self-administered questionnaire used to assess shoulder pain and functional disability.
6 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Annum Manzoor, MS OMPT, Riphah International University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. juli 2026

Primær fullføring (Antatt)

1. august 2026

Studiet fullført (Antatt)

1. september 2026

Datoer for studieregistrering

Først innsendt

21. juli 2026

Først innsendt som oppfylte QC-kriteriene

23. juli 2026

Først lagt ut (Faktiske)

24. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

24. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

23. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere